Perspective Therapeutics
CATX
CATX
105 hedge funds and large institutions have $385M invested in Perspective Therapeutics in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 9 increasing their positions, 44 reducing their positions, and 49 closing their positions.
Holders
105
Holders Change
–
Holders Change %
0%
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
51
Increased
9
Reduced
44
Closed
49
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
DM
1
Deerfield Management
New York
|
$28.1M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$12.8M |
| 3 |
CC
3
Commodore Capital
New York
|
$46.4M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$29.1M |
| 5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$2.02M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OPTFSNA
151
Old Point Trust & Financial Services N A
Newport News,
Virginia
| – | – | -2,500 | Closed |
|
|
SA
152
Scarborough Advisors
Annapolis,
Maryland
| – | – | -109 | Closed |
|
153
Mercer Global Advisors
Denver,
Colorado
| – | – | -4 | Closed |
|
|
CFGS
154
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
155
T. Rowe Price Associates
Baltimore,
Maryland
| $0 | 15,019 | +15,019 | New |
|